← FDA DRUG APPROVALS

FDA ANDA · ANDA075051

METOCLOPRAMIDE HYDROCHLORIDE

Sponsor: VISTAPHARM LLC

APPLICATION
ANDA075051
TYPE
ANDA
ORIGINAL APPROVAL
2001-01-26
LATEST ACTION
2012-08-31
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

METOCLOPRAMIDE HYDROCHLORIDEDiscontinued
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE/5ML · SOLUTION · ORAL

Approval history

2012-08-31Labeling · Supplement 4 · standardAP
2011-02-28Labeling · Supplement 3AP
2010-07-30REMS · Supplement 2AP
2001-01-26OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →